Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

MilliporeSigma™ Calbiochem™ PIM3 Kinase Inhibitor VII, M-110

Catalog No. 52652610MG Shop All MilliporeSigma Products
Change view
Click to view available options
Quantity:
10 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
52-652-610MG 10 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 52-652-610MG Supplier MilliporeSigma™ Supplier No. 52652610MG
Only null left
Add to Cart
Add to Cart

A cell-permeable hydroxyphenyl-propylidene-benzohydrazide compound that acts as a potent, ATP-competitive (Ki

A cell-permeable hydroxyphenyl-propylidene-benzohydrazide compound that acts as a potent, ATP-competitive (Ki = 0.3μM), and highly isoform-selective PIM inhibitor (IC50 = 2.5, 2.5, and 0.047μM against PIM1, PIM2, and PIM3, respectively; [ATP] = 10μM), while affecting CK2α2 only at much higher concentrations (IC50 = 5μM, [ATP] = 10μM) and exhibiting little or no activity against a panel of 258 other kinases (<40% inhibition at 5μM). Shown to inhibit PIM3-dependent STAT3 Tyr705 phosphorylation in DU-145 prostate cancer and MiaPaCa2 pancreatic cancer cells (by 73% and 83%, respectively; 10μM for 18 h), while displaying little effect toward STAT3 Tyr694 phosphoylation in 22RV1 cultures.
TRUSTED_SUSTAINABILITY

Specifications

Color Pale Yellow
Description 97% by HPLC
Molecular Formula C22H28ClN5O3
Formula Weight 445.9g/mol
Solubility DMSO
Content And Storage Protect from light
Form Solid
Quantity 10 mg
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.